Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
BMJ Open. 2023 Aug 9;13(8):e069149. doi: 10.1136/bmjopen-2022-069149.
Women in mid-life often develop chronic conditions and experience declines in physical health and function. Identifying factors associated with declines provides opportunity for targeted interventions. We derived and externally validated a risk score for clinically important declines over 10 years among women ages 55-65 using the Physical Component Summary Score (PCS) of the SF-36.
Derivation and validation of a risk score.
Two longitudinal cohorts from sites in the USA were used.
Women from the Study of Women's Health Across the Nation (SWAN) and women from the Women's Health Initiative (WHI) Observational Study and/or clinical trials.
A clinically important decline over 10 years among women ages 55-65 using the PCS of the SF-36 predictors was measured at the beginning of the 10 years of follow-up.
Seven factors-lower educational attainment, smoking, higher body mass index, history of cardiovascular disease, history of osteoarthritis, depressive symptoms and baseline PCS level-were found to be significant predictors of PCS decline among women in SWAN with an area under the curve (AUC)=0.71 and a Brier Score=0.14. The same factors were associated with a decline in PCS in WHI with an AUC=0.64 and a Brier Score=0.18. Regression coefficients from the SWAN analysis were used to estimate risk scores for PCS decline in both cohorts. Using a threshold of a 30% probability of a significant decline, the risk score created a binary test with a specificity between 89%-93% and an accuracy of 73%-79%.
Seven clinical variables were used to create a valid risk score for PCS declines that was replicated in an external cohort. The risk score provides a method for identifying women at high risk for a significant mid-life PCS decline.
中年女性常患有慢性疾病,并经历身体机能和健康的衰退。识别与衰退相关的因素为有针对性的干预提供了机会。我们使用 SF-36 的身体成分综合评分(PCS),从年龄在 55-65 岁的女性中得出并外部验证了一个在 10 年内出现临床显著下降的风险评分。
风险评分的推导和验证。
来自美国多个地点的两个纵向队列被使用。
来自妇女健康倡议观察研究和/或临床试验的妇女健康跨国家研究(SWAN)和妇女健康倡议(WHI)的女性。
在 10 年随访开始时,使用 SF-36 的 PCS 测量年龄在 55-65 岁的女性在 10 年内的临床显著下降。
在 SWAN 中,有 7 个因素(较低的教育程度、吸烟、较高的体重指数、心血管疾病史、骨关节炎史、抑郁症状和基线 PCS 水平)被发现是 PCS 下降的显著预测因素,曲线下面积(AUC)为 0.71,Brier 分数为 0.14。同样的因素与 WHI 中 PCS 的下降相关,AUC 为 0.64,Brier 分数为 0.18。SWAN 分析中的回归系数被用来估计两个队列中 PCS 下降的风险评分。使用 30%的显著下降概率作为阈值,风险评分创建了一个二分类测试,其特异性在 89%-93%之间,准确性在 73%-79%之间。
使用 7 个临床变量创建了一个用于 PCS 下降的有效风险评分,在外部队列中得到了复制。该风险评分提供了一种识别高风险中年女性 PCS 显著下降的方法。